These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pathogenesis of hyperlipidemia in the nephrotic syndrome. Attman PO, Alaupovic P. Am J Nephrol; 1990; 10 Suppl 1():69-75. PubMed ID: 2256478 [Abstract] [Full Text] [Related]
23. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism? Battula SB, Fitzsimons O, Moreno S, Owens D, Collins P, Johnson A, Tomkin GH. Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025 [Abstract] [Full Text] [Related]
25. The causal role of hypoalbuminemia in human nephrotic hyperlipidemia. Rahman M, Salamatullah Q, Ferdous Z, Hussain MA. Bangladesh Med Res Counc Bull; 1976 Jun; 2(1):64-70. PubMed ID: 190998 [Abstract] [Full Text] [Related]
27. [Genetic predisposition for the multiple metabolic syndrome. Part 4. Apolipoprotein E and lipoprotein (a)]. Sobra J, Ceska R. Cas Lek Cesk; 1999 Mar 29; 138(7):203-8. PubMed ID: 10510535 [Abstract] [Full Text] [Related]
35. Familial type V hyperlipoproteinaemia in identical twins homozygous for apoliprotein variant E2: report. Nye ER, Sutherland WH, Janus ED. N Z Med J; 1986 Mar 12; 99(797):146-9. PubMed ID: 3457291 [Abstract] [Full Text] [Related]
36. [The apolipoprotein E gene polymorphism in children with steroid-resistant idiopathic nephrotic syndrome]. Zeng H, Gao Y, Xu J, Zhang X, Wan G, Chen Z, Guo R, Chen Z. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Aug 12; 18(4):289-91. PubMed ID: 11484169 [Abstract] [Full Text] [Related]